Yesterday I referred to the impact of improved adherence to medicines on overall healthcare spending.
Most Recent Posts
Derek Thompson over at The Atlantic had an interesting post on his blog the other day looking at how the growing population of 65 and older is driving communications related and other technologies as well as businesses to meet their special needs.
Welcome to The Catalyst, part of PhRMA's new home on the web.
Telling the story of the biopharmaceutical sector is a daunting task, one that we strive to accomplish daily at PhRMA.
One new resource that I'm finding especially helpful in this effort is PhRMA's new Chart Pack, which visually conveys the value of the biopharmaceutical research sector, whether that value is demonstrated by saving lives, saving jobs, or saving long-term healthcare dollars.
President Obama's been speaking passionately about the importance of innovation to our economy recently. I was struck by his State of the Union speech where he said that: "Innovation doesn't just change our lives, it's how we make our living." That pretty well captures something we in the biopharmaceutical research sector have been talking about for a long time.
On Monday, Senator Leahy highlighted President Obama's Chamber of Commerce remarks in which he called for a need to reform our patent system. We're quick to recognize that patents - along with other forms of intellectual property - are a crucial incentive to innovate; in other words, they facilitate the work required to turn an idea into a usable product.
We are looking forward to becoming a more active participant in the health care conversation via our new blog.
Our goal is simple and straightforward. We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you and learn together.
Think of this post as our commitment to you.
U.S. biotechnology firms account for 80% of the world's research & development in biotechnology.
PhRMA works closely with patient advocates who represent every spectrum of disease - it's some of the most important work we do. Working hand-in-hand with patients, patient advocacy organizations are tasked with defending the rights of their patient groups, finding them the best care possible, and helping them find new ways to treat and manage their disease. The Mesothelioma Center, based in